Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Oct 06 2025

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-oct-06-2025-2

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated October 06, 2025, titled "Zydus receives approval from Health Canada for Liothyronine tablets 5 mcg and 25 mcg".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases